Discover
PRME
Prime Medicine, Inc.
3.89
2 x 2.83
2 x 4.67
bid
ask
+
0.20
5.42%
2 @ 07:00 AM
3.88 -0.01 (0.26%)
| Ytd | 12.10% | |
| 1y | 42.49% |
3.62
day range
3.95
2.67
52 week range
6.94
| Open | 3.64 | Prev Close | 3.69 | Low | 3.62 | High | 3.95 | Mkt Cap | 702.60M |
| Vol | 3.77M | Avg Vol | 2.63M | EPS | -1.23 | P/E | N/A | Forward P/E | -3.96 |
| Beta | 2.67 | Short Ratio | 5.85 | Inst. Own | 44.38% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 3.27 | 200-d Avg | 3.94 | 1yr Est | 6.50 |
| Income Statement | |||
| Total Revenue | 856.00K | ||
| Revenues (USD) | 856.00K | ||
| Gross Profit | 856.00K | ||
| Operating Expenses | 51.51M | ||
| Research and Development Expense | 34.10M | ||
| Selling, General and Administrative Expense | 17.41M | ||
| Operating Income | -50.65M | ||
| Net Income | -49.12M | ||
| Net Income Common Stock | -49.12M | ||
| Net Income Common Stock (USD) | -49.12M | ||
| Consolidated Income | -49.12M | ||
| Earnings per Basic Share | -0.28 | ||
| Earnings per Basic Share (USD) | -0.28 | ||
| Earnings per Diluted Share | -0.28 | ||
| Earning Before Interest & Taxes (EBIT) | -49.12M | ||
| Earning Before Interest & Taxes (USD) | -49.12M | ||
| Weighted Average Shares | 177.10M | ||
| Weighted Average Shares Diluted | 177.10M | ||
| Balance Sheet | |||
| Cash and Equivalents | 77.80M | ||
| Cash and Equivalents (USD) | 77.80M | ||
| Investments | 71.39M | ||
| Investments Current | 71.39M | ||
| Current Assets | 137.89M | ||
| Property, Plant & Equipment Net | 142.15M | ||
| Total Assets | 294.73M | ||
| Debt Current | 8.55M | ||
| Total Debt | 114.51M | ||
| Current Liabilities | 36.29M | ||
| Debt Non-Current | 105.97M | ||
| Total Liabilities | 218.03M | ||
| Accumulated Retained Earnings (Deficit) | -937.48M | ||
| Accumulated Other Comprehensive Income | -1000 | ||
| Shareholders Equity | 76.70M | ||
| Shareholders Equity (USD) | 76.70M | ||
| Assets Non-Current | 156.84M | ||
| Total Debt (USD) | 114.51M | ||
| Deferred Revenue | 65.10M | ||
| Liabilities Non-Current | 181.74M | ||
| Trade and Non-Trade Payables | 12.33M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.70M | ||
| Net Cash Flow from Financing | 393.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.07M | ||
| Capital Expenditure | -214.00K | ||
| Issuance (Purchase) of Equity Shares | 393.00K | ||
| Net Cash Flow from Investing | 43.39M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 43.61M | ||
| Net Cash Flow from Operations | -42.71M | ||
| Share Based Compensation | 4.64M | ||